Jan 27 (Reuters) - The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai (4523.T), opens new tab and partner Biogen's (BIIB.O), opens new tab Alzheimer's drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback